[go: up one dir, main page]

EE200300228A - Tiotroopium- ja salmeteroolsooladel põhinevad ravimkompositsioonid - Google Patents

Tiotroopium- ja salmeteroolsooladel põhinevad ravimkompositsioonid

Info

Publication number
EE200300228A
EE200300228A EEP200300228A EEP200300228A EE200300228A EE 200300228 A EE200300228 A EE 200300228A EE P200300228 A EEP200300228 A EE P200300228A EE P200300228 A EEP200300228 A EE P200300228A EE 200300228 A EE200300228 A EE 200300228A
Authority
EE
Estonia
Prior art keywords
tiotropium
pharmaceutical compositions
compositions based
salmeterol salts
salmeterol
Prior art date
Application number
EEP200300228A
Other languages
English (en)
Inventor
Schmelzer Christel
Nagel Juergen
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of EE200300228A publication Critical patent/EE200300228A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EEP200300228A 2000-11-13 2001-11-09 Tiotroopium- ja salmeteroolsooladel põhinevad ravimkompositsioonid EE200300228A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10056104A DE10056104A1 (de) 2000-11-13 2000-11-13 Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols
PCT/EP2001/012962 WO2002038154A1 (de) 2000-11-13 2001-11-09 Neue arzneimittelkompositionen auf der basis von tiotropiumsalzen und salzen des salmeterols

Publications (1)

Publication Number Publication Date
EE200300228A true EE200300228A (et) 2003-10-15

Family

ID=7663071

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300228A EE200300228A (et) 2000-11-13 2001-11-09 Tiotroopium- ja salmeteroolsooladel põhinevad ravimkompositsioonid

Country Status (32)

Country Link
EP (3) EP1808174A1 (et)
JP (2) JP4282322B2 (et)
KR (2) KR100886094B1 (et)
CN (1) CN1678318A (et)
AT (2) ATE291428T1 (et)
AU (3) AU2791002A (et)
BG (1) BG107781A (et)
BR (1) BR0115226A (et)
CA (1) CA2429012A1 (et)
CY (1) CY1106774T1 (et)
CZ (1) CZ20031444A3 (et)
DE (3) DE10056104A1 (et)
DK (2) DK1335728T3 (et)
EA (1) EA007904B1 (et)
EC (1) ECSP034571A (et)
EE (1) EE200300228A (et)
ES (2) ES2240549T3 (et)
HR (1) HRP20030378A2 (et)
HU (1) HUP0301447A3 (et)
IL (2) IL155718A0 (et)
MX (1) MXPA03004164A (et)
NO (1) NO20032111L (et)
NZ (1) NZ526400A (et)
PL (1) PL205330B1 (et)
PT (2) PT1335728E (et)
RS (2) RS20090105A (et)
SG (1) SG167657A1 (et)
SI (2) SI1514546T1 (et)
SK (2) SK286939B6 (et)
UA (1) UA74853C2 (et)
WO (1) WO2002038154A1 (et)
ZA (1) ZA200302921B (et)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214687B2 (en) 1999-07-14 2007-05-08 Almirall Ag Quinuclidine derivatives and medicinal compositions containing the same
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
AU1534501A (en) * 1999-11-23 2001-06-04 Glaxo Group Limited Pharmaceutical formulations of salmeterol
WO2003024452A1 (de) * 2001-09-14 2003-03-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue arzneimittel zur inhalation
US7311894B2 (en) 2002-03-28 2007-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations containing an anticholinergic
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
DE10256080A1 (de) * 2002-11-29 2004-06-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropiumhaltige Arzneimittelkombination für die Inhalation
US7250426B2 (en) 2002-11-29 2007-07-31 Boehringer Ingelheim Pharma Gmbh & Co Kg Tiotropium-containing pharmaceutical combination for inhalation
KR20050085650A (ko) * 2002-12-16 2005-08-29 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 타이오트로피움 함유 ｈｆｃ 용액 제형
UA83813C2 (ru) * 2002-12-20 2008-08-26 Бёрингер Ингельхайм Фарма Гмбх & Ко. Кг Порошковое лекарственное средство, которое содержит соль тиотропия и ксинафоат салметерола
DE10345065A1 (de) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
UA82414C2 (uk) * 2003-11-03 2008-04-10 Бёрингер Ингельхайм Интернациональ Гмбх Солі тіотропію, спосіб їх одержання, а також лікарські композиції, які їх містять
ES2342468T3 (es) * 2003-11-03 2010-07-07 Boehringer Ingelheim International Gmbh Procedimiento para la preparacion de sales de tiotropio.
WO2005115465A1 (en) * 2004-05-31 2005-12-08 Almirall Prodesfarma S.A. Combinations comprising antimuscarinic agents and pde4 inhibitors
ES2257152B1 (es) * 2004-05-31 2007-07-01 Laboratorios Almirall S.A. Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
SI1881980T1 (sl) 2005-05-02 2012-12-31 Boehringer Ingelheim International Gmbh Nove kristalinične oblike tiotropijevega bromida
CA2617897A1 (en) * 2005-08-06 2007-02-15 Boehringer Ingelheim International Gmbh Method for the treatment of dyspnea comprising combined administration of tiotropium salts and salts of salmeterol
ES2298049B1 (es) 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US20120220557A1 (en) * 2011-02-17 2012-08-30 Chiesi Farmaceutici S.P.A. Liquid propellant-free formulation comprising an antimuscarinic drug
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
JP6335798B2 (ja) * 2012-02-28 2018-05-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規噴射剤含有チオトロピウム製剤
WO2015065222A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Фармацевтический ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких, содержащий в качестве активного вещества микронизированный тиотропия бромид, и способ его получения
TW201835041A (zh) 2017-02-17 2018-10-01 印度商托仁特生技有限公司 具β-腎上腺素促效劑及抗蕈毒活性化合物
WO2019142214A1 (en) * 2018-01-19 2019-07-25 Cipla Limited Pharmaceutical composition comprising tiotropium for inhalation
CN116196298A (zh) * 2018-07-26 2023-06-02 四川海思科制药有限公司 一种含格隆铵盐的气雾剂药物组合物及其制备方法与应用
WO2020019952A1 (zh) * 2018-07-26 2020-01-30 四川海思科制药有限公司 一种含格隆铵盐及茚达特罗盐的气雾剂药物组合物及其制备方法与应用
US11826382B2 (en) 2020-05-01 2023-11-28 Tygrus, LLC Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
US11642372B2 (en) 2020-05-01 2023-05-09 Tygrus, LLC Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
WO2022119661A1 (en) * 2020-12-04 2022-06-09 Tygrus, LLC THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES
US12042514B2 (en) 2020-05-01 2024-07-23 Tygrus, LLC Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
IL303404A (en) * 2020-12-04 2023-08-01 Tygrus Llc THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1158996C (zh) * 1998-07-24 2004-07-28 杰格研究股份公司 药用气溶胶制剂
DE19835346A1 (de) * 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
DE19847970A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähige Wirkstoff-Formulierung
DE19847971A1 (de) * 1998-10-17 1999-09-02 Schiering Verfahren und Einrichtung zur Verhinderung von Filterbränden (Staubfilter)
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
DE19961300A1 (de) * 1999-12-18 2001-06-21 Asta Medica Ag Vorratssystem für Arzneimittel in Pulverform und damit ausgestatteter Inhalator

Also Published As

Publication number Publication date
BG107781A (bg) 2004-06-30
ES2240549T3 (es) 2005-10-16
HUP0301447A2 (hu) 2003-10-28
SK286939B6 (sk) 2009-07-06
PT1514546E (pt) 2007-06-15
AU2791002A (en) 2002-05-21
IL155718A0 (en) 2003-11-23
JP2004513146A (ja) 2004-04-30
ECSP034571A (es) 2003-06-25
YU35503A (sh) 2006-05-25
KR20080079701A (ko) 2008-09-01
EA200300503A1 (ru) 2004-12-30
ATE362761T1 (de) 2007-06-15
EP1335728B1 (de) 2005-03-23
RS20090105A (sr) 2009-07-15
RS50286B (sr) 2009-09-08
SK7412003A3 (en) 2003-10-07
NO20032111L (no) 2003-07-08
SI1514546T1 (sl) 2007-10-31
JP2005068163A (ja) 2005-03-17
HUP0301447A3 (en) 2007-10-29
JP4282322B2 (ja) 2009-06-17
PT1335728E (pt) 2005-05-31
EP1335728A1 (de) 2003-08-20
CN1678318A (zh) 2005-10-05
DE10056104A1 (de) 2002-05-23
AU2002227910B2 (en) 2007-03-01
CY1106774T1 (el) 2012-05-23
JP4282594B2 (ja) 2009-06-24
ES2287629T3 (es) 2007-12-16
NO20032111D0 (no) 2003-05-12
CZ20031444A3 (cs) 2003-08-13
EA007904B1 (ru) 2007-02-27
IL155718A (en) 2010-06-30
AU2007202303A1 (en) 2007-06-14
SI1335728T1 (en) 2005-08-31
NZ526400A (en) 2005-09-30
PL365989A1 (en) 2005-01-24
KR100886094B1 (ko) 2009-02-27
KR20030065509A (ko) 2003-08-06
DK1335728T3 (da) 2005-04-18
CA2429012A1 (en) 2002-05-16
DE50112535D1 (de) 2007-07-05
UA74853C2 (en) 2006-02-15
EP1808174A1 (de) 2007-07-18
PL205330B1 (pl) 2010-04-30
MXPA03004164A (es) 2005-08-16
SK286950B6 (sk) 2009-08-06
AU2007202303B2 (en) 2010-01-21
EP1514546B1 (de) 2007-05-23
ATE291428T1 (de) 2005-04-15
DE50105729D1 (de) 2005-04-28
WO2002038154A1 (de) 2002-05-16
KR100940752B1 (ko) 2010-02-11
HRP20030378A2 (en) 2005-04-30
ZA200302921B (en) 2004-04-19
BR0115226A (pt) 2003-10-07
DK1514546T3 (da) 2007-09-24
SG167657A1 (en) 2011-01-28
EP1514546A1 (de) 2005-03-16

Similar Documents

Publication Publication Date Title
EE200300228A (et) Tiotroopium- ja salmeteroolsooladel põhinevad ravimkompositsioonid
NO2023030I1 (no) Apixaban and pharmaceutical acceptable salts thereof
ATE355271T1 (de) Pharmazeutische zusammensetzung
ITTO20010008A0 (it) Formulazione farmaceutica
NO20025450L (no) Ny farmasöytisk sammensetning
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
FI20105657L (fi) Farmaseuttisia koostumuksia
EE04331B1 (et) Kiiresti lahustuv peroraalne ravimvorm
DK1178832T3 (da) Nye lægemiddelsammensætninger på basis af tiotropiumbromid og salmeterol
ITMI20010748A0 (it) Composizioni farmaceutiche
DE60118008D1 (de) Pharmazeutische zusammensetzungen mit amlodipinmaleat
AU2002227910A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
NO20030627D0 (no) Hydrogel-drevet medikament doseringsform
ATE404180T1 (de) Geschmacksmaskierte pharmazeutische partikel
DK1353919T3 (da) Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme
FI4823U1 (fi) Muunnetulla tavalla vapauttava lääkeformulaatio
NO20026123L (no) Farmasöytiske sammensetninger
ATE366128T1 (de) Pharmazeutische zusammensetzung
NO20032614D0 (no) Farmasöytisk sammensetning med forbedret absorbabilitet
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
DE10291905D2 (de) Pharmazeutische Zusammensetzung
MXPA03001857A (es) Composicones medicinales.
DE10107261B4 (de) Pharmazeutische Zusammensetzung
EE200200689A (et) Ravimkoostised
SE0004677D0 (sv) Intraaxonal läkemedelsadministration